Artennua is an optimized version of Artemisia annua, a medicinal plant used for centuries in Chinese Medicine that is the only natural source of Artemisinin. Artemisinin is the molecule recommended by the WHO to treat malaria.
Artemisinin, its derivatives, and other secondary metabolites contained in the plant Artemisia annua, have the potential to treat a broad range of diseases and afflictions. However, Artemisia annua produces very low quantities of artemisinin and thus its global supply is limited.
As scientists and social entrepreneurs, we have used natural plant biopharming methods to improve some characteristics of the Artemisia annua plant meaning its therapeutic properties can now be exploited more extensively.
Iberzoo+ Propet 2022 (6th edition) The sixth edition of Iberzoo+Propet returned to total attendance after two years marked by the Covid-19 pandemic. The reunion of professionals from the pet sector ended with the participation of more than 16,900 professional participants from 43 different countries. (Iberzoo,2022) These statistics reveal the eagerness to generate new professional synergies,…
As with humans, it is very common for our pets to suffer from cancer. Which in animals can be treated and in many cases the tumor can be remitted with the appropriate treatment. It is estimated that cancer is the leading cause of death in geriatric dogs and cats. Therefore, significant advances have been made…
Artemisia annua is an aromatic herbaceous plant native to Asia, a species that stands out from the rest of its genus as an excellent and important source of clinically proven therapeutic compounds. Artemisia annua L. produces a range of complex terpenoids in its trichomes, among which artemisinin is of particular interest for the treatment of…
